223-OR: Characterization of Regenerative Adult Islet Progenitor Cells from Human Pancreatic Tissue

Introduction & Objective: To identify and characterize expandable islet progenitor cells in human pancreatic tissue capable of regenerating islet organoids in vitro and in vivo. Methods: Single cell RNA-sequencing was performed on dissociated pancreatic tissue from normal human pancreas and panc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73, p.1
Hauptverfasser: Darden, Carly, Kuncha, Jayachandra, Mattke, Jordan D, Lawrence, Michael C, Naziruddin, Bashoo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 1
container_title Diabetes (New York, N.Y.)
container_volume 73
creator Darden, Carly
Kuncha, Jayachandra
Mattke, Jordan D
Lawrence, Michael C
Naziruddin, Bashoo
description Introduction & Objective: To identify and characterize expandable islet progenitor cells in human pancreatic tissue capable of regenerating islet organoids in vitro and in vivo. Methods: Single cell RNA-sequencing was performed on dissociated pancreatic tissue from normal human pancreas and pancreatitis to identify islet progenitor cell populations, gene signatures, and unique markers expressed in vitro and in vivo. Islet progenitors were validated by QPCR and flow cytometry. Islet progenitor cells were isolated by flow-sorting and expanded to produce functional islet-like organoids. Undifferentiated islet progenitor cells and differentiated islet-like organoids were transplanted into STZ-induced diabetic nude mice to assess islet function. Grafts and native pancreas were assessed for expression of islet organoids. Results: A total of 9807 cells were analyzed and multiple cell types were identified and matched to pancreatic cell subtypes, including activated stellate cells (86%), ductal cell (9.2%), beta cell (3.8%), and alpha cell (0.5%). Human islet progenitors were identified expressing stem-cell marker Procr, immature beta-cell marker CD9, and islet endocrine progenitor marker RGS16. These Procr+, CD9+, RGS16+ cells also expressed ductal epithelial, stellate, and mesenchymal cell markers indicative of epithelial-mesenchymal transition. Undifferentiated islet progenitor cells could migrate to the damaged mouse pancreas to produce human islet organoids in vivo within 28 days post-transplantation. Islet progenitor cells could be differentiated to produce and release insulin and glucagon in vitro and restore islet cell function in vivo. Conclusion: Procr+, CD9+, RGS16+ islet progenitor cells expanded from human pancreatic tissue retain regenerative properties to produce functional islet cell organoids in vitro and in vivo for potential use in islet cell replacement therapy or strategies to regenerate islet cells in the native pancreas.
doi_str_mv 10.2337/db24-223-OR
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_3100299736</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3100299736</sourcerecordid><originalsourceid>FETCH-proquest_journals_31002997363</originalsourceid><addsrcrecordid>eNqNi81KAzEUhYO04NS68gUuuE7NjzTEnQxKXVlKF-5KZuaOTkkTvUlc-PQG9AHKWRwO33cYu5FipbQ2d0On7rlSmr_uLlgjrbZcK_M2Y40QUnFprLlki5SOQoh1TcO6P_sB2g9Hrs9I04_LUwwQR9jhOwakur8RHofiM7wkjxm2FCuZciRo0fsEI8UTbMrJBdi60BPWTw_7KaWCSzYfnU94_d9X7Pb5ad9u-CfFr4IpH46xUKjooKUQylqj1_o86xcjZkpx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3100299736</pqid></control><display><type>article</type><title>223-OR: Characterization of Regenerative Adult Islet Progenitor Cells from Human Pancreatic Tissue</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Darden, Carly ; Kuncha, Jayachandra ; Mattke, Jordan D ; Lawrence, Michael C ; Naziruddin, Bashoo</creator><creatorcontrib>Darden, Carly ; Kuncha, Jayachandra ; Mattke, Jordan D ; Lawrence, Michael C ; Naziruddin, Bashoo</creatorcontrib><description>Introduction &amp; Objective: To identify and characterize expandable islet progenitor cells in human pancreatic tissue capable of regenerating islet organoids in vitro and in vivo. Methods: Single cell RNA-sequencing was performed on dissociated pancreatic tissue from normal human pancreas and pancreatitis to identify islet progenitor cell populations, gene signatures, and unique markers expressed in vitro and in vivo. Islet progenitors were validated by QPCR and flow cytometry. Islet progenitor cells were isolated by flow-sorting and expanded to produce functional islet-like organoids. Undifferentiated islet progenitor cells and differentiated islet-like organoids were transplanted into STZ-induced diabetic nude mice to assess islet function. Grafts and native pancreas were assessed for expression of islet organoids. Results: A total of 9807 cells were analyzed and multiple cell types were identified and matched to pancreatic cell subtypes, including activated stellate cells (86%), ductal cell (9.2%), beta cell (3.8%), and alpha cell (0.5%). Human islet progenitors were identified expressing stem-cell marker Procr, immature beta-cell marker CD9, and islet endocrine progenitor marker RGS16. These Procr+, CD9+, RGS16+ cells also expressed ductal epithelial, stellate, and mesenchymal cell markers indicative of epithelial-mesenchymal transition. Undifferentiated islet progenitor cells could migrate to the damaged mouse pancreas to produce human islet organoids in vivo within 28 days post-transplantation. Islet progenitor cells could be differentiated to produce and release insulin and glucagon in vitro and restore islet cell function in vivo. Conclusion: Procr+, CD9+, RGS16+ islet progenitor cells expanded from human pancreatic tissue retain regenerative properties to produce functional islet cell organoids in vitro and in vivo for potential use in islet cell replacement therapy or strategies to regenerate islet cells in the native pancreas.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db24-223-OR</identifier><language>eng</language><publisher>New York: American Diabetes Association</publisher><subject>Beta cells ; CD9 antigen ; Cell differentiation ; Diabetes mellitus ; Flow cytometry ; Gene flow ; Glucagon ; Islet cells ; Organoids ; Pancreas ; Pancreas transplantation ; Pancreatic islet transplantation ; Pancreatitis ; Progenitor cells ; Recovery of function ; Stellate cells ; Xenografts</subject><ispartof>Diabetes (New York, N.Y.), 2024-06, Vol.73, p.1</ispartof><rights>Copyright American Diabetes Association Jun 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Darden, Carly</creatorcontrib><creatorcontrib>Kuncha, Jayachandra</creatorcontrib><creatorcontrib>Mattke, Jordan D</creatorcontrib><creatorcontrib>Lawrence, Michael C</creatorcontrib><creatorcontrib>Naziruddin, Bashoo</creatorcontrib><title>223-OR: Characterization of Regenerative Adult Islet Progenitor Cells from Human Pancreatic Tissue</title><title>Diabetes (New York, N.Y.)</title><description>Introduction &amp; Objective: To identify and characterize expandable islet progenitor cells in human pancreatic tissue capable of regenerating islet organoids in vitro and in vivo. Methods: Single cell RNA-sequencing was performed on dissociated pancreatic tissue from normal human pancreas and pancreatitis to identify islet progenitor cell populations, gene signatures, and unique markers expressed in vitro and in vivo. Islet progenitors were validated by QPCR and flow cytometry. Islet progenitor cells were isolated by flow-sorting and expanded to produce functional islet-like organoids. Undifferentiated islet progenitor cells and differentiated islet-like organoids were transplanted into STZ-induced diabetic nude mice to assess islet function. Grafts and native pancreas were assessed for expression of islet organoids. Results: A total of 9807 cells were analyzed and multiple cell types were identified and matched to pancreatic cell subtypes, including activated stellate cells (86%), ductal cell (9.2%), beta cell (3.8%), and alpha cell (0.5%). Human islet progenitors were identified expressing stem-cell marker Procr, immature beta-cell marker CD9, and islet endocrine progenitor marker RGS16. These Procr+, CD9+, RGS16+ cells also expressed ductal epithelial, stellate, and mesenchymal cell markers indicative of epithelial-mesenchymal transition. Undifferentiated islet progenitor cells could migrate to the damaged mouse pancreas to produce human islet organoids in vivo within 28 days post-transplantation. Islet progenitor cells could be differentiated to produce and release insulin and glucagon in vitro and restore islet cell function in vivo. Conclusion: Procr+, CD9+, RGS16+ islet progenitor cells expanded from human pancreatic tissue retain regenerative properties to produce functional islet cell organoids in vitro and in vivo for potential use in islet cell replacement therapy or strategies to regenerate islet cells in the native pancreas.</description><subject>Beta cells</subject><subject>CD9 antigen</subject><subject>Cell differentiation</subject><subject>Diabetes mellitus</subject><subject>Flow cytometry</subject><subject>Gene flow</subject><subject>Glucagon</subject><subject>Islet cells</subject><subject>Organoids</subject><subject>Pancreas</subject><subject>Pancreas transplantation</subject><subject>Pancreatic islet transplantation</subject><subject>Pancreatitis</subject><subject>Progenitor cells</subject><subject>Recovery of function</subject><subject>Stellate cells</subject><subject>Xenografts</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNi81KAzEUhYO04NS68gUuuE7NjzTEnQxKXVlKF-5KZuaOTkkTvUlc-PQG9AHKWRwO33cYu5FipbQ2d0On7rlSmr_uLlgjrbZcK_M2Y40QUnFprLlki5SOQoh1TcO6P_sB2g9Hrs9I04_LUwwQR9jhOwakur8RHofiM7wkjxm2FCuZciRo0fsEI8UTbMrJBdi60BPWTw_7KaWCSzYfnU94_d9X7Pb5ad9u-CfFr4IpH46xUKjooKUQylqj1_o86xcjZkpx</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Darden, Carly</creator><creator>Kuncha, Jayachandra</creator><creator>Mattke, Jordan D</creator><creator>Lawrence, Michael C</creator><creator>Naziruddin, Bashoo</creator><general>American Diabetes Association</general><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20240601</creationdate><title>223-OR: Characterization of Regenerative Adult Islet Progenitor Cells from Human Pancreatic Tissue</title><author>Darden, Carly ; Kuncha, Jayachandra ; Mattke, Jordan D ; Lawrence, Michael C ; Naziruddin, Bashoo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_31002997363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Beta cells</topic><topic>CD9 antigen</topic><topic>Cell differentiation</topic><topic>Diabetes mellitus</topic><topic>Flow cytometry</topic><topic>Gene flow</topic><topic>Glucagon</topic><topic>Islet cells</topic><topic>Organoids</topic><topic>Pancreas</topic><topic>Pancreas transplantation</topic><topic>Pancreatic islet transplantation</topic><topic>Pancreatitis</topic><topic>Progenitor cells</topic><topic>Recovery of function</topic><topic>Stellate cells</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Darden, Carly</creatorcontrib><creatorcontrib>Kuncha, Jayachandra</creatorcontrib><creatorcontrib>Mattke, Jordan D</creatorcontrib><creatorcontrib>Lawrence, Michael C</creatorcontrib><creatorcontrib>Naziruddin, Bashoo</creatorcontrib><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Darden, Carly</au><au>Kuncha, Jayachandra</au><au>Mattke, Jordan D</au><au>Lawrence, Michael C</au><au>Naziruddin, Bashoo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>223-OR: Characterization of Regenerative Adult Islet Progenitor Cells from Human Pancreatic Tissue</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><date>2024-06-01</date><risdate>2024</risdate><volume>73</volume><spage>1</spage><pages>1-</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><abstract>Introduction &amp; Objective: To identify and characterize expandable islet progenitor cells in human pancreatic tissue capable of regenerating islet organoids in vitro and in vivo. Methods: Single cell RNA-sequencing was performed on dissociated pancreatic tissue from normal human pancreas and pancreatitis to identify islet progenitor cell populations, gene signatures, and unique markers expressed in vitro and in vivo. Islet progenitors were validated by QPCR and flow cytometry. Islet progenitor cells were isolated by flow-sorting and expanded to produce functional islet-like organoids. Undifferentiated islet progenitor cells and differentiated islet-like organoids were transplanted into STZ-induced diabetic nude mice to assess islet function. Grafts and native pancreas were assessed for expression of islet organoids. Results: A total of 9807 cells were analyzed and multiple cell types were identified and matched to pancreatic cell subtypes, including activated stellate cells (86%), ductal cell (9.2%), beta cell (3.8%), and alpha cell (0.5%). Human islet progenitors were identified expressing stem-cell marker Procr, immature beta-cell marker CD9, and islet endocrine progenitor marker RGS16. These Procr+, CD9+, RGS16+ cells also expressed ductal epithelial, stellate, and mesenchymal cell markers indicative of epithelial-mesenchymal transition. Undifferentiated islet progenitor cells could migrate to the damaged mouse pancreas to produce human islet organoids in vivo within 28 days post-transplantation. Islet progenitor cells could be differentiated to produce and release insulin and glucagon in vitro and restore islet cell function in vivo. Conclusion: Procr+, CD9+, RGS16+ islet progenitor cells expanded from human pancreatic tissue retain regenerative properties to produce functional islet cell organoids in vitro and in vivo for potential use in islet cell replacement therapy or strategies to regenerate islet cells in the native pancreas.</abstract><cop>New York</cop><pub>American Diabetes Association</pub><doi>10.2337/db24-223-OR</doi></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2024-06, Vol.73, p.1
issn 0012-1797
1939-327X
language eng
recordid cdi_proquest_journals_3100299736
source EZB-FREE-00999 freely available EZB journals
subjects Beta cells
CD9 antigen
Cell differentiation
Diabetes mellitus
Flow cytometry
Gene flow
Glucagon
Islet cells
Organoids
Pancreas
Pancreas transplantation
Pancreatic islet transplantation
Pancreatitis
Progenitor cells
Recovery of function
Stellate cells
Xenografts
title 223-OR: Characterization of Regenerative Adult Islet Progenitor Cells from Human Pancreatic Tissue
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T09%3A07%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=223-OR:%20Characterization%20of%20Regenerative%20Adult%20Islet%20Progenitor%20Cells%20from%20Human%20Pancreatic%20Tissue&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=Darden,%20Carly&rft.date=2024-06-01&rft.volume=73&rft.spage=1&rft.pages=1-&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db24-223-OR&rft_dat=%3Cproquest%3E3100299736%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3100299736&rft_id=info:pmid/&rfr_iscdi=true